The drug “Armadin”, which was in the leading positions a few years ago, returned to the top 20 rating. For 2019, he managed to ” win ” 5 positions and take the 20th line.
Supporting data are given in the weekly “Apteka” no. 4 (1225) dated February 3, 2020.. with a description of the rating results.
In General, the structure of pharmacy sales of goods of Ukrainian and foreign production for the Ukrainian pharmaceutical market is characterized by a predominance of foreign goods in monetary terms. In natural terms, domestic products prevail.
Such a high rating, as belonging to the TOP 20 brands of medicines in terms of pharmacy sales in monetary terms, indicates a high demand for the domestic drug Armadin for Ukrainian patients.
We thank the healthcare professionals of Ukraine for their trust.